Methods and compositions for the treatment of b cell...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/16 (2006.01) A61K 36/48 (2006.01) A61P 35/00 (2006.01) C07K 14/42 (2006.01)

Patent

CA 2545709

The ability of certain members of the FRIL family of proteins to inhibit the proliferation and/or survival of FRIL-sensitive cancer cells is disclosed. The FRIL proteins can be used in methods of treatment for such FRIL-sensitive cancers, in the manufacture of medicaments for the treatment of such cancers, and for imaging, detecting or locating such cancers. FRIL-sensitive cancers include, without limitation, B cell lymphomas and T cell cutaneous lymphomas.

Cette invention décrit la capacité de certains membres de la famille FRIL de protéines d'inhiber la prolifération et/ou la survie des cellules cancéreuses sensibles aux protéines FRIL. Les protéines FRIL peuvent être utilisées dans des procédés pour traiter ces cancers sensibles aux protéines FRIL, dans la fabrication de médicaments pour traiter ces cancers, et dans l'imagerie, la détection ou la localisation de ces cancers. Les cancers sensibles aux protéines FRIL sont notamment les lymphomes des lymphocytes B et les lymphomes cutanés des lymphocytes T.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for the treatment of b cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for the treatment of b cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the treatment of b cell... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1415752

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.